{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:42:35Z","timestamp":1772134955907,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1038\/s41433-023-02852-x","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T13:02:17Z","timestamp":1701435737000},"page":"1155-1161","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Macular oedema secondary to rhegmatogenous retinal detachment repair: risk factors for resistance to first-line therapy and long-term response to dexamethasone intravitreal implant"],"prefix":"10.1038","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0798-1353","authenticated-orcid":false,"given":"Soufiane","family":"Souissi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Violaine","family":"Allou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Trucchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannick","family":"Le Mer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramin","family":"Tadayoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aude","family":"Couturier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"key":"2852_CR1","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/0002-9394(53)90302-X","volume":"36","author":"AR Irvine","year":"1953","unstructured":"Irvine AR. A newly defined vitreous syndrome following cataract surgery, interpreted according to recent concepts of the structure of the vitreous. Am J Ophthalmol. 1953;36:599\u2013619.","journal-title":"Am J Ophthalmol"},{"key":"2852_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1001\/archopht.1966.03850010648005","volume":"76","author":"JD Gass","year":"1966","unstructured":"Gass JD, Norton EW. Cystoid Macular edema and papilledema following cataract extraction: a fluorescein fundoscopic and angiographic study. Arch Ophthalmol. 1966;76:646\u201361.","journal-title":"Arch Ophthalmol"},{"key":"2852_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0039-6257(76)90045-X","volume":"21","author":"AR Irvine","year":"1976","unstructured":"Irvine AR. Cystoid maculopathy. Surv Ophthalmol. 1976;21:1\u201317.","journal-title":"Surv Ophthalmol"},{"key":"2852_CR4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1159\/000455280","volume":"58","author":"D Zur","year":"2017","unstructured":"Zur D, Loewenstein A. Postsurgical cystoid macular edema. Dev Ophthalmol. 2017;58:178\u201390.","journal-title":"Dev Ophthalmol"},{"key":"2852_CR5","doi-asserted-by":"publisher","first-page":"971758","DOI":"10.1155\/2013\/971758","volume":"2013","author":"V Romano","year":"2013","unstructured":"Romano V, Angi M, Scotti F, et al. Inflammation and macular oedema after pars plana vitrectomy. Mediators Inflamm. 2013;2013:971758.","journal-title":"Mediators Inflamm"},{"key":"2852_CR6","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1080\/02713683.2021.1929330","volume":"46","author":"MR Starr","year":"2021","unstructured":"Starr MR, Cai L, Obeid A, Ryan EH, Eliott D, Ryan C, et al. Primary Retinal Detachment Outcomes (PRO) Study Group. Risk factors for presence of cystoid macular edema following rhegmatogenous retinal detachment surgery. Curr Eye Res. 2021;46:1867\u201375.","journal-title":"Curr Eye Res"},{"key":"2852_CR7","doi-asserted-by":"publisher","first-page":"4914","DOI":"10.3390\/jcm11164914","volume":"11","author":"M Merad","year":"2022","unstructured":"Merad M, V\u00e9rit\u00e9 F, Baudin F, Ghezala IB, Meillon C, Bron AM, et al. Cystoid macular edema after rhegmatogenous retinal detachment repair with pars plana vitrectomy: rate, risk factors, and outcomes. J Clin Med. 2022;11:4914.","journal-title":"J Clin Med"},{"key":"2852_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/09273948.2019.1652330","volume":"29","author":"I Chatziralli","year":"2021","unstructured":"Chatziralli I, Theodossiadis G, Dimitriou E, Kazantzis D, Theodossiadis P. Macular edema after successful pars plana vitrectomy for rhegmatogenous retinal detachment: factors affecting edema development and considerations for treatment. Ocul Immunol Inflamm. 2021;29:187\u201392.","journal-title":"Ocul Immunol Inflamm"},{"key":"2852_CR9","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ajo.2022.05.008","volume":"241","author":"BR McKay","year":"2022","unstructured":"McKay BR, Bansal A, Kryshtalskyj M, Wong DT, Berger A, Muni RH. Evaluation of subretinal fluid drainage techniques during pars plana vitrectomy for primary rhegmatogenous retinal detachment-ELLIPSOID study. Am J Ophthalmol. 2022;241:227\u201337.","journal-title":"Am J Ophthalmol"},{"key":"2852_CR10","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/j.jcrs.0000000000001097","volume":"49","author":"J Du","year":"2023","unstructured":"Du J, Landa G. Impact of prior pars plana vitrectomy on development of cystoid macular edema after uneventful cataract surgery. J Cataract Refract Surg. 2023;49:266\u201371.","journal-title":"J Cataract Refract Surg"},{"key":"2852_CR11","doi-asserted-by":"publisher","first-page":"827","DOI":"10.4103\/ijo.IJO_735_17","volume":"66","author":"S Sengupta","year":"2018","unstructured":"Sengupta S, Vasavada D, Pan U, Sindal M. Factors predicting response of pseudophakic cystoid macular edema to topical steroids and nepafenac. Indian J Ophthalmol. 2018;66:827\u201330.","journal-title":"Indian J Ophthalmol"},{"key":"2852_CR12","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1136\/bjophthalmol-2014-306159","volume":"99","author":"D Bellocq","year":"2015","unstructured":"Bellocq D, Korobelnik JF, Burillon C, Voirin N, Dot C, Souied E, et al. Effectiveness and safety of dexamethasone implants for post-surgical macular oedema including Irvine-Gass syndrome: the EPISODIC study. Br J Ophthalmol. 2015;99:979\u201383.","journal-title":"Br J Ophthalmol"},{"key":"2852_CR13","first-page":"333","volume":"101","author":"D Bellocq","year":"2017","unstructured":"Bellocq D, Pierre-Kahn V, Matonti F, Burillon C, Voirin N, Dot C, et al. Effectiveness and safety of dexamethasone implants for postsurgical macular oedema including Irvine-Gass syndrome: the EPISODIC-2 study. Br J Ophthalmol. 2017;101:333\u201341.","journal-title":"Br J Ophthalmol"},{"key":"2852_CR14","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1097\/IAE.0000000000001720","volume":"38","author":"A Thanos","year":"2018","unstructured":"Thanos A, Todorich B, Yonekawa Y, Papakostas TD, Khundkar T, Eliott D, et al. Dexamethasone intravitreal implant for the treatment of recalcitrant macular edema after rhegmatogenous retinal detachment repair. Retina. 2018;38:1084\u201390.","journal-title":"Retina"},{"key":"2852_CR15","doi-asserted-by":"crossref","first-page":"3946531","DOI":"10.1155\/2020\/3946531","volume":"2020","author":"S Freissinger","year":"2020","unstructured":"Freissinger S, Vounotrypidis E, Wolf A, Kortuem KU, Shajari M, Sakkias F, et al. Evaluation of functional outcomes and OCT-biomarkers after intravitreal dexamethasone implant for postoperative cystoid macular edema in vitrectomized eyes. J Ophthalmol. 2020;2020:3946531.","journal-title":"J Ophthalmol"},{"key":"2852_CR16","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1167\/iovs.05-0981","volume":"47","author":"K Schulze-Bonsel","year":"2006","unstructured":"Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual acuities \u201chand motion\u201d and \u201ccounting fingers\u201d can be quantified with the freiburg visual acuity test. Investig Ophthalmol Vis Sci. 2006;47:1236\u201340.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"2852_CR17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/0002-9394(83)90264-7","volume":"95","author":"K Miyake","year":"1983","unstructured":"Miyake K, Miyake Y, Maekubo K, Asakura M, Manabe R. Incidence of cystoid macular edema after retinal detachment surgery and the use of topical indomethacin. Am J Ophthalmol. 1983;95:451\u20136.","journal-title":"Am J Ophthalmol"},{"key":"2852_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/aos.14940","volume":"100","author":"M Gebler","year":"2022","unstructured":"Gebler M, Pfeiffer S, Callizo J, Hoerauf H, Feltgen N, Bemme S. Incidence and risk factors for macular oedema after primary rhegmatogenous retinal detachment surgery: a prospective single-centre study. Acta Ophthalmol. 2022;100:295\u2013301.","journal-title":"Acta Ophthalmol"},{"key":"2852_CR19","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1097\/IAE.0000000000003475","volume":"42","author":"M Gharbiya","year":"2022","unstructured":"Gharbiya M, Visioli G, Iannetti L, Iannaccone A, Tamburrelli AC, Marenco M, et al. Comparison between scleral buckling and vitrectomy in the onset of cystoid macular edema and epiretinal membrane after rhegmatogenous retinal detachment repair. Retina. 2022;42:1268\u201376.","journal-title":"Retina"},{"key":"2852_CR20","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.ophtha.2015.10.009","volume":"123","author":"V Daien","year":"2016","unstructured":"Daien V, Papinaud L, Domerg C, Lacombe S, Daures JP, Villain M. Incidence and characteristics of cystoid macular edema after cataract surgery. Ophthalmology. 2016;123:663\u20134.","journal-title":"Ophthalmology"},{"key":"2852_CR21","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/eye.2016.264","volume":"31","author":"TT Lai","year":"2017","unstructured":"Lai TT, Huang JS, Yeh PT. Incidence and risk factors for cystoid macular edema following scleral buckling. Eye. 2017;31:566\u201371.","journal-title":"Eye"},{"key":"2852_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40942-020-00254-9","volume":"7","author":"C Pole","year":"2021","unstructured":"Pole C, Chehaibou I, Govetto A, Garrity S, Schwartz SD, Hubschman JP. Macular edema after rhegmatogenous retinal detachment repair: risk factors, OCT analysis, and treatment responses. Int J Retina Vitr. 2021;7:9.","journal-title":"Int J Retina Vitr"},{"key":"2852_CR23","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0039-6257(05)80093-1","volume":"39","author":"GA Peyman","year":"1995","unstructured":"Peyman GA, Schulman JA, Sullivan B. Perfluorocarbon liquids in ophthalmology. Surv Ophthalmol. 1995;39:375\u201395.","journal-title":"Surv Ophthalmol"},{"key":"2852_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/antiox9010007","volume":"9","author":"E Ankamah","year":"2019","unstructured":"Ankamah E, Sebag J, Ng E, Nolan JM. Vitreous antioxidants, degeneration, and vitreo-retinopathy: exploring the links. Antioxidants. 2019;9:7.","journal-title":"Antioxidants"},{"key":"2852_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/bjophthalmol-2019-313991","volume":"104","author":"B Rajesh","year":"2020","unstructured":"Rajesh B, Zarranz-Ventura J, Fung AT, Busch C, Sahoo NK, Rodriguez-Valdes PJ, et al. Safety of 6000 intravitreal dexamethasone implants. Br J Ophthalmol. 2020;104:39\u201346.","journal-title":"Br J Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02852-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02852-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02852-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T13:34:43Z","timestamp":1730727283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02852-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["2852"],"URL":"https:\/\/doi.org\/10.1038\/s41433-023-02852-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2710254\/v1","asserted-by":"object"}]},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,1]]},"assertion":[{"value":"19 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}